First, Gal-3 is not a specific cardiac biomarker, and increased circulating concentrations have been reported in other noncardiac diseases, such as diabetes mellitus, kidney disease, and cancer in humans [2,3,4]. This evidence concerns the gene LGALS3 and kidney disorder.